申请人:TAKEDA PHARMACEUTICALS CO
公开号:WO2017222083A1
公开(公告)日:2017-12-28
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein n, X1, X2, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12and R13 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
本发明提供了式(I)的化合物及其药用盐,其中n、X1、X2、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12和R13如规范中定义的那样,其制备方法,含有它们的药物组合物以及它们在治疗中的应用。